Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease
Publication
, Journal Article
McCrory, DC; Brown, CD
Published in: Evidence-Based Medicine
May 1, 2003
Duke Scholars
Published In
Evidence-Based Medicine
DOI
ISSN
1356-5524
Publication Date
May 1, 2003
Volume
8
Issue
3
Start / End Page
74
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McCrory, D. C., & Brown, C. D. (2003). Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine, 8(3), 74. https://doi.org/10.1136/ebm.8.3.74
McCrory, D. C., and C. D. Brown. “Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease.” Evidence-Based Medicine 8, no. 3 (May 1, 2003): 74. https://doi.org/10.1136/ebm.8.3.74.
McCrory DC, Brown CD. Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine. 2003 May 1;8(3):74.
McCrory, D. C., and C. D. Brown. “Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease.” Evidence-Based Medicine, vol. 8, no. 3, May 2003, p. 74. Scopus, doi:10.1136/ebm.8.3.74.
McCrory DC, Brown CD. Review: Ipratropium is not more effective than β2 agonists for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine. 2003 May 1;8(3):74.
Published In
Evidence-Based Medicine
DOI
ISSN
1356-5524
Publication Date
May 1, 2003
Volume
8
Issue
3
Start / End Page
74
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 1103 Clinical Sciences